HEADER TRANSFERASE 22-DEC-13 4CJR TITLE INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTEGRASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 50-212; COMPND 5 EC: 2.7.7.7; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET KEYWDS TRANSFERASE, STRUCTURE BASED DRUG DESIGN EXPDTA X-RAY DIFFRACTION AUTHOR T.S.PEAT REVDAT 4 20-DEC-23 4CJR 1 JRNL REMARK REVDAT 3 25-JUN-14 4CJR 1 JRNL REVDAT 2 26-FEB-14 4CJR 1 JRNL REVDAT 1 08-JAN-14 4CJR 0 JRNL AUTH T.S.PEAT,O.DOLEZAL,J.NEWMAN,D.MOBLEY,J.J.DEADMAN JRNL TITL INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL JRNL TITL 2 CHALLENGE. JRNL REF J.COMPUT.AIDED MOL.DES. V. 28 347 2014 JRNL REFN ISSN 0920-654X JRNL PMID 24532034 JRNL DOI 10.1007/S10822-014-9721-7 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0032 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.59 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 33533 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.195 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1777 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2493 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2250 REMARK 3 BIN FREE R VALUE SET COUNT : 134 REMARK 3 BIN FREE R VALUE : 0.2800 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2300 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 122 REMARK 3 SOLVENT ATOMS : 164 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.22000 REMARK 3 B22 (A**2) : 0.22000 REMARK 3 B33 (A**2) : -0.70000 REMARK 3 B12 (A**2) : 0.22000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.112 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.102 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.060 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.875 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.945 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2655 ; 0.006 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2476 ; 0.004 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3649 ; 1.176 ; 1.981 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5726 ; 0.808 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 341 ; 4.934 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 109 ;31.629 ;25.321 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 449 ;13.795 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 8 ; 9.436 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 412 ; 0.058 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3095 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 571 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1266 ; 1.271 ; 2.753 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1264 ; 1.261 ; 2.748 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1598 ; 2.148 ; 4.610 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1389 ; 1.665 ; 3.152 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES REFINED INDIVIDUALLY REMARK 4 REMARK 4 4CJR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-DEC-13. REMARK 100 THE DEPOSITION ID IS D_1290059292. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-APR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95374 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35338 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 45.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.40 REMARK 200 R MERGE FOR SHELL (I) : 0.26000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3ZSQ REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE PROTEIN WAS CONCENTRATED TO 5.5 REMARK 280 MG/ML IN 40 MM TRIS PH 8.0, 250 MM NACL, 30 MM MGCL2, 5 MM DTT REMARK 280 AND SET UP IN A 1:1 RATIO WITH 1.6 TO 2.0 M AMMONIUM SULFATE, REMARK 280 100 MM SODIUM ACETATE BUFFER PH 5.0 TO 5.5., PH 5.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 22.39767 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 44.79533 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5750 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -169.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 30 REMARK 465 GLY A 31 REMARK 465 SER A 32 REMARK 465 SER A 33 REMARK 465 HIS A 34 REMARK 465 HIS A 35 REMARK 465 HIS A 36 REMARK 465 HIS A 37 REMARK 465 HIS A 38 REMARK 465 HIS A 39 REMARK 465 SER A 40 REMARK 465 SER A 41 REMARK 465 GLY A 42 REMARK 465 LEU A 43 REMARK 465 VAL A 44 REMARK 465 PRO A 45 REMARK 465 ARG A 46 REMARK 465 GLY A 47 REMARK 465 SER A 48 REMARK 465 HIS A 49 REMARK 465 MET A 50 REMARK 465 HIS A 51 REMARK 465 GLY A 52 REMARK 465 GLN A 53 REMARK 465 VAL A 54 REMARK 465 ASP A 55 REMARK 465 SER A 56 REMARK 465 LYS A 188 REMARK 465 GLY A 189 REMARK 465 GLY A 190 REMARK 465 ILE A 191 REMARK 465 GLY A 192 REMARK 465 THR A 210 REMARK 465 LYS A 211 REMARK 465 GLU A 212 REMARK 465 MET B 30 REMARK 465 GLY B 31 REMARK 465 SER B 32 REMARK 465 SER B 33 REMARK 465 HIS B 34 REMARK 465 HIS B 35 REMARK 465 HIS B 36 REMARK 465 HIS B 37 REMARK 465 HIS B 38 REMARK 465 HIS B 39 REMARK 465 SER B 40 REMARK 465 SER B 41 REMARK 465 GLY B 42 REMARK 465 LEU B 43 REMARK 465 VAL B 44 REMARK 465 PRO B 45 REMARK 465 ARG B 46 REMARK 465 GLY B 47 REMARK 465 SER B 48 REMARK 465 HIS B 49 REMARK 465 MET B 50 REMARK 465 HIS B 51 REMARK 465 GLY B 52 REMARK 465 GLN B 53 REMARK 465 VAL B 54 REMARK 465 ASP B 55 REMARK 465 SER B 56 REMARK 465 LYS B 188 REMARK 465 GLY B 189 REMARK 465 GLY B 190 REMARK 465 ILE B 191 REMARK 465 GLY B 192 REMARK 465 THR B 210 REMARK 465 LYS B 211 REMARK 465 GLU B 212 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU B 87 O ACT B 1215 2.16 REMARK 500 O HOH A 2082 O HOH A 2083 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1210 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1210 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1211 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1211 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1212 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1212 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1213 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1213 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1214 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1214 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 1215 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FYM A 1215 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FYM B 1216 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4CJ3 RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CJ4 RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CJ5 RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CJE RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CJF RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CJK RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CJL RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CJP RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CJQ RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CJS RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CJT RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CJU RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CJV RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CJW RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE DBREF 4CJR A 50 212 UNP Q76353 Q76353_9HIV1 50 212 DBREF 4CJR B 50 212 UNP Q76353 Q76353_9HIV1 50 212 SEQADV 4CJR MET A 30 UNP Q76353 EXPRESSION TAG SEQADV 4CJR GLY A 31 UNP Q76353 EXPRESSION TAG SEQADV 4CJR SER A 32 UNP Q76353 EXPRESSION TAG SEQADV 4CJR SER A 33 UNP Q76353 EXPRESSION TAG SEQADV 4CJR HIS A 34 UNP Q76353 EXPRESSION TAG SEQADV 4CJR HIS A 35 UNP Q76353 EXPRESSION TAG SEQADV 4CJR HIS A 36 UNP Q76353 EXPRESSION TAG SEQADV 4CJR HIS A 37 UNP Q76353 EXPRESSION TAG SEQADV 4CJR HIS A 38 UNP Q76353 EXPRESSION TAG SEQADV 4CJR HIS A 39 UNP Q76353 EXPRESSION TAG SEQADV 4CJR SER A 40 UNP Q76353 EXPRESSION TAG SEQADV 4CJR SER A 41 UNP Q76353 EXPRESSION TAG SEQADV 4CJR GLY A 42 UNP Q76353 EXPRESSION TAG SEQADV 4CJR LEU A 43 UNP Q76353 EXPRESSION TAG SEQADV 4CJR VAL A 44 UNP Q76353 EXPRESSION TAG SEQADV 4CJR PRO A 45 UNP Q76353 EXPRESSION TAG SEQADV 4CJR ARG A 46 UNP Q76353 EXPRESSION TAG SEQADV 4CJR GLY A 47 UNP Q76353 EXPRESSION TAG SEQADV 4CJR SER A 48 UNP Q76353 EXPRESSION TAG SEQADV 4CJR HIS A 49 UNP Q76353 EXPRESSION TAG SEQADV 4CJR SER A 56 UNP Q76353 CYS 56 ENGINEERED MUTATION SEQADV 4CJR ASP A 139 UNP Q76353 PHE 139 ENGINEERED MUTATION SEQADV 4CJR HIS A 185 UNP Q76353 PHE 185 ENGINEERED MUTATION SEQADV 4CJR MET B 30 UNP Q76353 EXPRESSION TAG SEQADV 4CJR GLY B 31 UNP Q76353 EXPRESSION TAG SEQADV 4CJR SER B 32 UNP Q76353 EXPRESSION TAG SEQADV 4CJR SER B 33 UNP Q76353 EXPRESSION TAG SEQADV 4CJR HIS B 34 UNP Q76353 EXPRESSION TAG SEQADV 4CJR HIS B 35 UNP Q76353 EXPRESSION TAG SEQADV 4CJR HIS B 36 UNP Q76353 EXPRESSION TAG SEQADV 4CJR HIS B 37 UNP Q76353 EXPRESSION TAG SEQADV 4CJR HIS B 38 UNP Q76353 EXPRESSION TAG SEQADV 4CJR HIS B 39 UNP Q76353 EXPRESSION TAG SEQADV 4CJR SER B 40 UNP Q76353 EXPRESSION TAG SEQADV 4CJR SER B 41 UNP Q76353 EXPRESSION TAG SEQADV 4CJR GLY B 42 UNP Q76353 EXPRESSION TAG SEQADV 4CJR LEU B 43 UNP Q76353 EXPRESSION TAG SEQADV 4CJR VAL B 44 UNP Q76353 EXPRESSION TAG SEQADV 4CJR PRO B 45 UNP Q76353 EXPRESSION TAG SEQADV 4CJR ARG B 46 UNP Q76353 EXPRESSION TAG SEQADV 4CJR GLY B 47 UNP Q76353 EXPRESSION TAG SEQADV 4CJR SER B 48 UNP Q76353 EXPRESSION TAG SEQADV 4CJR HIS B 49 UNP Q76353 EXPRESSION TAG SEQADV 4CJR SER B 56 UNP Q76353 CYS 56 ENGINEERED MUTATION SEQADV 4CJR ASP B 139 UNP Q76353 PHE 139 ENGINEERED MUTATION SEQADV 4CJR HIS B 185 UNP Q76353 PHE 185 ENGINEERED MUTATION SEQRES 1 A 183 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 183 LEU VAL PRO ARG GLY SER HIS MET HIS GLY GLN VAL ASP SEQRES 3 A 183 SER SER PRO GLY ILE TRP GLN LEU ASP CYS THR HIS LEU SEQRES 4 A 183 GLU GLY LYS VAL ILE LEU VAL ALA VAL HIS VAL ALA SER SEQRES 5 A 183 GLY TYR ILE GLU ALA GLU VAL ILE PRO ALA GLU THR GLY SEQRES 6 A 183 GLN GLU THR ALA TYR PHE LEU LEU LYS LEU ALA GLY ARG SEQRES 7 A 183 TRP PRO VAL LYS THR VAL HIS THR ASP ASN GLY SER ASN SEQRES 8 A 183 PHE THR SER THR THR VAL LYS ALA ALA CYS TRP TRP ALA SEQRES 9 A 183 GLY ILE LYS GLN GLU ASP GLY ILE PRO TYR ASN PRO GLN SEQRES 10 A 183 SER GLN GLY VAL ILE GLU SER MET ASN LYS GLU LEU LYS SEQRES 11 A 183 LYS ILE ILE GLY GLN VAL ARG ASP GLN ALA GLU HIS LEU SEQRES 12 A 183 LYS THR ALA VAL GLN MET ALA VAL PHE ILE HIS ASN HIS SEQRES 13 A 183 LYS ARG LYS GLY GLY ILE GLY GLY TYR SER ALA GLY GLU SEQRES 14 A 183 ARG ILE VAL ASP ILE ILE ALA THR ASP ILE GLN THR LYS SEQRES 15 A 183 GLU SEQRES 1 B 183 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 183 LEU VAL PRO ARG GLY SER HIS MET HIS GLY GLN VAL ASP SEQRES 3 B 183 SER SER PRO GLY ILE TRP GLN LEU ASP CYS THR HIS LEU SEQRES 4 B 183 GLU GLY LYS VAL ILE LEU VAL ALA VAL HIS VAL ALA SER SEQRES 5 B 183 GLY TYR ILE GLU ALA GLU VAL ILE PRO ALA GLU THR GLY SEQRES 6 B 183 GLN GLU THR ALA TYR PHE LEU LEU LYS LEU ALA GLY ARG SEQRES 7 B 183 TRP PRO VAL LYS THR VAL HIS THR ASP ASN GLY SER ASN SEQRES 8 B 183 PHE THR SER THR THR VAL LYS ALA ALA CYS TRP TRP ALA SEQRES 9 B 183 GLY ILE LYS GLN GLU ASP GLY ILE PRO TYR ASN PRO GLN SEQRES 10 B 183 SER GLN GLY VAL ILE GLU SER MET ASN LYS GLU LEU LYS SEQRES 11 B 183 LYS ILE ILE GLY GLN VAL ARG ASP GLN ALA GLU HIS LEU SEQRES 12 B 183 LYS THR ALA VAL GLN MET ALA VAL PHE ILE HIS ASN HIS SEQRES 13 B 183 LYS ARG LYS GLY GLY ILE GLY GLY TYR SER ALA GLY GLU SEQRES 14 B 183 ARG ILE VAL ASP ILE ILE ALA THR ASP ILE GLN THR LYS SEQRES 15 B 183 GLU HET SO4 A1210 5 HET SO4 A1211 5 HET SO4 A1212 5 HET SO4 A1213 5 HET CL A1214 1 HET FYM A1215 36 HET SO4 B1210 5 HET SO4 B1211 5 HET SO4 B1212 5 HET SO4 B1213 5 HET SO4 B1214 5 HET ACT B1215 4 HET FYM B1216 36 HETNAM SO4 SULFATE ION HETNAM CL CHLORIDE ION HETNAM FYM 2-METHOXY-6-[[[6-[(4-METHOXYPHENYL)METHYLCARBAMOYL]-1, HETNAM 2 FYM 3-BENZODIOXOL-5-YL]METHYL-METHYL-AMINO]METHYL]BENZOIC HETNAM 3 FYM ACID HETNAM ACT ACETATE ION FORMUL 3 SO4 9(O4 S 2-) FORMUL 7 CL CL 1- FORMUL 8 FYM 2(C27 H28 N2 O7) FORMUL 14 ACT C2 H3 O2 1- FORMUL 16 HOH *164(H2 O) HELIX 1 1 THR A 93 TRP A 108 1 16 HELIX 2 2 ASN A 117 SER A 123 1 7 HELIX 3 3 SER A 123 GLY A 134 1 12 HELIX 4 4 PRO A 145 ARG A 166 1 22 HELIX 5 5 ASP A 167 ALA A 169 5 3 HELIX 6 6 HIS A 171 LYS A 186 1 16 HELIX 7 7 SER A 195 GLN A 209 1 15 HELIX 8 8 THR B 93 TRP B 108 1 16 HELIX 9 9 ASN B 117 SER B 123 1 7 HELIX 10 10 SER B 123 GLY B 134 1 12 HELIX 11 11 PRO B 145 ARG B 166 1 22 HELIX 12 12 ASP B 167 ALA B 169 5 3 HELIX 13 13 HIS B 171 LYS B 186 1 16 HELIX 14 14 SER B 195 GLN B 209 1 15 SHEET 1 AA 5 ILE A 84 ILE A 89 0 SHEET 2 AA 5 LYS A 71 HIS A 78 -1 O VAL A 72 N ILE A 89 SHEET 3 AA 5 ILE A 60 LEU A 68 -1 O GLN A 62 N VAL A 77 SHEET 4 AA 5 THR A 112 HIS A 114 1 O THR A 112 N TRP A 61 SHEET 5 AA 5 LYS A 136 GLU A 138 1 O LYS A 136 N VAL A 113 SHEET 1 BA 5 ILE B 84 ILE B 89 0 SHEET 2 BA 5 LYS B 71 HIS B 78 -1 O VAL B 72 N ILE B 89 SHEET 3 BA 5 ILE B 60 LEU B 68 -1 O GLN B 62 N VAL B 77 SHEET 4 BA 5 THR B 112 HIS B 114 1 O THR B 112 N TRP B 61 SHEET 5 BA 5 LYS B 136 GLU B 138 1 O LYS B 136 N VAL B 113 SITE 1 AC1 7 THR B 66 HIS B 67 LYS B 111 LYS B 136 SITE 2 AC1 7 LYS B 159 HOH B2007 HOH B2049 SITE 1 AC2 7 THR A 66 HIS A 67 LYS A 111 LYS A 159 SITE 2 AC2 7 HOH A2007 HOH A2060 HOH A2088 SITE 1 AC3 5 LYS B 71 HIS B 171 LEU B 172 HOH B2010 SITE 2 AC3 5 HOH B2058 SITE 1 AC4 6 LYS A 71 HIS A 171 LEU A 172 HOH A2010 SITE 2 AC4 6 HOH A2068 HOH A2070 SITE 1 AC5 6 GLY A 94 SER A 123 THR A 124 THR A 125 SITE 2 AC5 6 HOH A2028 HOH A2052 SITE 1 AC6 6 GLY B 94 SER B 123 THR B 124 THR B 125 SITE 2 AC6 6 HOH B2024 HOH B2042 SITE 1 AC7 5 GLU A 85 PHE A 100 LYS A 103 ARG B 107 SITE 2 AC7 5 SO4 B1213 SITE 1 AC8 5 ARG A 107 SO4 A1213 GLU B 85 PHE B 100 SITE 2 AC8 5 LYS B 103 SITE 1 AC9 8 LYS A 103 HOH A2018 HOH A2019 HOH A2071 SITE 2 AC9 8 TYR B 99 LYS B 103 ACT B1215 HOH B2070 SITE 1 BC1 1 HIS B 185 SITE 1 BC2 7 TYR A 99 LYS A 103 HOH A2036 SO4 B1214 SITE 2 BC2 7 HOH B2016 HOH B2059 HOH B2060 SITE 1 BC3 11 ASP A 167 GLN A 168 ALA A 169 GLU A 170 SITE 2 BC3 11 HIS A 171 THR A 174 HOH A2089 GLN B 95 SITE 3 BC3 11 ALA B 98 ALA B 128 ALA B 129 SITE 1 BC4 11 GLN A 95 ALA A 98 ALA A 128 ALA A 129 SITE 2 BC4 11 HOH A2054 ASP B 167 GLN B 168 ALA B 169 SITE 3 BC4 11 GLU B 170 HIS B 171 THR B 174 CRYST1 71.184 71.184 67.193 90.00 90.00 120.00 P 31 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014048 0.008111 0.000000 0.00000 SCALE2 0.000000 0.016221 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014883 0.00000